These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
124 related articles for article (PubMed ID: 4415024)
1. Perphenazine concentrations in human whole blood. A pilot study during anti-psychotic therapy using different administration forms. Hansen CE; Larsen NE Psychopharmacologia; 1974 Jun; 37(1):31-6. PubMed ID: 4415024 [No Abstract] [Full Text] [Related]
2. [Therapy control of perphenazine. 2. Clinical aspects]. Kjeldsen CS; Larsen NE; Kragh-Sørensen P; Andersen E; Brøsen K; Gerholt F; Glue P; Hørder M; Klitgaard NA; Krarup G Ugeskr Laeger; 1991 Aug; 153(34):2339-43. PubMed ID: 1897043 [TBL] [Abstract][Full Text] [Related]
3. [Therapy control of perphenazine in paranoid conditions. 1. Organizational aspects]. Rask PH; Krarup G; Kragh-Sørensen P; Andersen E; Brøsen K; Gerholt F; Glue P; Hørder M; Kjeldsen CS; Klitgaard NA Ugeskr Laeger; 1991 Aug; 153(34):2336-9. PubMed ID: 1897042 [TBL] [Abstract][Full Text] [Related]
4. [Clinical experiences with perphenazine enanthate]. Rafter B Nord Psykiatr Tidsskr; 1971; 25(4):371-4. PubMed ID: 5154124 [No Abstract] [Full Text] [Related]
5. Therapeutic advantages of monitoring plasma concentrations of perphenazine in clinical practice. Hansen LB; Larsen NE Psychopharmacology (Berl); 1985; 87(1):16-9. PubMed ID: 3933033 [TBL] [Abstract][Full Text] [Related]
6. Determination of perphenazine and its sulphoxide metabolite in human plasma after therapeutic doses by gas chromatography. Larsen NE; Naestoft J J Chromatogr; 1975 Jun; 109(2):259-64. PubMed ID: 1150819 [TBL] [Abstract][Full Text] [Related]
7. Plasma concentrations of perphenazine and its sulphoxide metabolite during continuous oral treatment. Hansen LB; Larsen NE Psychopharmacology (Berl); 1977 Jul; 53(2):127-30. PubMed ID: 408838 [TBL] [Abstract][Full Text] [Related]
8. [Clinical study on five depot neuroleptics. Comparison of effective profiles of fluphenazinedecanoate, fluspirilene, penfluridol, perphenazine-enanthate and pipothiazinepalmitate]. Angst J; Woggon B Arzneimittelforschung; 1975 Feb; 25(2):267-70. PubMed ID: 1091272 [TBL] [Abstract][Full Text] [Related]
9. [Paranoid psychosis in acute intermittent porphyria treated with perphenazine]. Stibolt O; Thunell S Ugeskr Laeger; 1998 Nov; 160(45):6529-31. PubMed ID: 9816964 [TBL] [Abstract][Full Text] [Related]
10. [Perphenazine enantate in long-term therapy of psychoses]. Gunby B Nord Psykiatr Tidsskr; 1968; 22(4):358-60. PubMed ID: 5710606 [No Abstract] [Full Text] [Related]
11. Plasma levels of perphenazine (Trilafon) related to development of extrapyramidal side effects. Hansen LB; Larsen NE; Vestergård P Psychopharmacology (Berl); 1981; 74(4):306-9. PubMed ID: 6794071 [TBL] [Abstract][Full Text] [Related]
12. [The serum perphenazine level in patients with schizophrenia and the results of treatment]. Nurowska K; Welbel L; Lipska B; Szukalski B Psychiatr Pol; 1987; 21(1):20-5. PubMed ID: 3615673 [No Abstract] [Full Text] [Related]
13. Prolactin and blood pressure responses to perphenazine in human subjects: comparison of the oral and intramuscular routes. Musey VC; Preedy JR; Musey PI; Blank MS; Brogan DR; Bain RP; Collins DC Am J Med Sci; 1986 Jun; 291(6):380-5. PubMed ID: 3717195 [TBL] [Abstract][Full Text] [Related]
14. Perphenazine serum levels in patients on standard doses. Haffner F Psychopharmacol Ser; 1989; 7():280-3. PubMed ID: 2687863 [No Abstract] [Full Text] [Related]